Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-07
2006-03-07
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S253000
Reexamination Certificate
active
07008959
ABSTRACT:
The invention relates to a novel crystalline form of irbesartan to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.
REFERENCES:
patent: 5270317 (1993-12-01), Bernhart et al.
patent: 5352788 (1994-10-01), Bernhart et al.
patent: 5559233 (1996-09-01), Bernhart et al.
patent: 5629331 (1997-05-01), Caron et al.
patent: 0 708 103 (1996-04-01), None
patent: WO 91/14679 (1991-10-01), None
Markham et al., Drugs, 59(5), 1187-1206, May 2000 (Abstract).
See, Expert. Opin. Pharmacother., 2(11), 1795-1804, 2001.
Simon et al., Am J. Cardiol., 82, 179-182, 1998.
M. Bauer et al, J. Chem. Soc., Perkin Trans. 2, No. 2, pp. 475-481, 1998.
Chemical Abstracts, vol. 129, No. 6, Aug. 10, 1998, Abstract No. 74251.
Franc Bruno
Hoff Christian
Kiang San
Lindrud Mark D.
Monnier Olivier
Lin Jiang
Powers Fiona T.
Sanofi-Aventis
LandOfFree
Form of irbesartan, processes for obtaining the said and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Form of irbesartan, processes for obtaining the said and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Form of irbesartan, processes for obtaining the said and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3544236